- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
The contraindications for ribociclib mainly include severe allergic reactions, specific heart diseases, and severe liver injury. For special ...
Ribociclib is a selective CDK4/6 inhibitor, which is mainly used to treat advanced or metastatic breast cancer with hormone receptor positive (...
The contraindications for Abemaciclib mainly involve allergic reactions, pregnancy, and severe liver injury. For special populations, the dosag...
Abemaciclib is an oral CDK4/6 inhibitor, which is mainly used for the treatment of advanced or metastatic breast cancer with hormone receptor p...
Abemaciclib, as a CDK4/6 inhibitor, requires attention to blood toxicity, liver and kidney function monitoring, embryo fetal toxicity, and drug...
As a CDK4/6 inhibitor, Abemaciclib is mainly used in the treatment of HR+/HER2 breast cancer. Its side effects involve the blood system, digest...
As an endothelin receptor antagonist, Macitentan's precautions mainly involve embryotoxicity, liver function monitoring and blood system effect...
Macitentan, as an endothelin receptor antagonist, is mainly used for the treatment of pulmonary arterial hypertension. Its side effects involve...
Idelalisib, as a PI3K δ inhibitor, should be monitored for liver toxicity, infection risk, and medication management in special populations. It...
Idelalisib, as a PI3K δ inhibitor, has side effects mainly including hepatotoxicity, severe infections, and gastrointestinal reactions, which n...
